HEADER TRANSFERASE 14-AUG-19 6SK2 TITLE HSNMT1 IN COMPLEX WITH BOTH MYRCOA AND ACETYLATED-GKSFSKPR PEPTIDE TITLE 2 REVEALS N-TERMINAL LYSINE MYRISTOYLATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE 1,TYPE I N- COMPND 5 MYRISTOYLTRANSFERASE,PEPTIDE N-MYRISTOYLTRANSFERASE 1; COMPND 6 EC: 2.3.1.97; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: APOPTOSIS-INDUCING FACTOR 3; COMPND 10 CHAIN: D, F; COMPND 11 SYNONYM: APOPTOSIS-INDUCING FACTOR-LIKE PROTEIN; COMPND 12 EC: 1.-.-.-; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 OTHER_DETAILS: EPSILON MYRISTOYLATION, N-TERMINAL LYSINE COMPND 16 MYRISTOYLATION IN THE CRYSTAL. ACETYLATED PEPTIDE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NMT1, NMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 DERIVATIVE; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS E-MYRISTOYLATION, NMT, MYRISTOYLTRANSFERASE TYPE1, ACYLTRANSFERASE, KEYWDS 2 GNAT, GCN5-RELATED N-ACETYLTRANSFERASES, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.DIAN,F.B.RIVIERE,T.ASENSIO,C.GIGLIONE,T.MEINNEL REVDAT 3 31-JAN-24 6SK2 1 REMARK REVDAT 2 07-DEC-22 6SK2 1 SEQADV LINK REVDAT 1 18-MAR-20 6SK2 0 JRNL AUTH C.DIAN,I.PEREZ-DORADO,F.RIVIERE,T.ASENSIO,P.LEGRAND, JRNL AUTH 2 M.RITZEFELD,M.SHEN,E.COTA,T.MEINNEL,E.W.TATE,C.GIGLIONE JRNL TITL HIGH-RESOLUTION SNAPSHOTS OF HUMAN N-MYRISTOYLTRANSFERASE IN JRNL TITL 2 ACTION ILLUMINATE A MECHANISM PROMOTING N-TERMINAL LYS AND JRNL TITL 3 GLY MYRISTOYLATION. JRNL REF NAT COMMUN V. 11 1132 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32111831 JRNL DOI 10.1038/S41467-020-14847-3 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.374 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 124981 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.965 REMARK 3 FREE R VALUE TEST SET COUNT : 6205 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.7875 - 5.9004 1.00 3986 190 0.1707 0.1826 REMARK 3 2 5.9004 - 4.6845 1.00 3969 186 0.1484 0.1976 REMARK 3 3 4.6845 - 4.0927 1.00 3946 220 0.1282 0.1728 REMARK 3 4 4.0927 - 3.7187 1.00 3964 223 0.1390 0.1664 REMARK 3 5 3.7187 - 3.4522 1.00 3958 198 0.1493 0.1920 REMARK 3 6 3.4522 - 3.2487 1.00 3986 170 0.1610 0.1866 REMARK 3 7 3.2487 - 3.0860 1.00 3956 213 0.1679 0.2245 REMARK 3 8 3.0860 - 2.9517 1.00 3996 199 0.1811 0.2155 REMARK 3 9 2.9517 - 2.8381 1.00 3986 209 0.1850 0.2384 REMARK 3 10 2.8381 - 2.7402 1.00 3949 185 0.1906 0.2688 REMARK 3 11 2.7402 - 2.6545 1.00 3965 202 0.1915 0.2829 REMARK 3 12 2.6545 - 2.5786 1.00 3942 222 0.1891 0.2478 REMARK 3 13 2.5786 - 2.5107 1.00 3962 214 0.1898 0.2271 REMARK 3 14 2.5107 - 2.4495 1.00 3957 195 0.1854 0.2857 REMARK 3 15 2.4495 - 2.3938 1.00 3948 225 0.1781 0.2462 REMARK 3 16 2.3938 - 2.3429 1.00 3941 204 0.1717 0.2408 REMARK 3 17 2.3429 - 2.2960 1.00 3998 216 0.1800 0.2194 REMARK 3 18 2.2960 - 2.2527 1.00 3932 212 0.1980 0.2826 REMARK 3 19 2.2527 - 2.2124 1.00 3959 235 0.1867 0.2446 REMARK 3 20 2.2124 - 2.1749 1.00 3901 231 0.1914 0.2336 REMARK 3 21 2.1749 - 2.1399 1.00 3938 215 0.2000 0.3116 REMARK 3 22 2.1399 - 2.1069 1.00 4020 206 0.2068 0.2163 REMARK 3 23 2.1069 - 2.0759 1.00 3921 166 0.2077 0.2717 REMARK 3 24 2.0759 - 2.0467 1.00 4004 193 0.2035 0.2813 REMARK 3 25 2.0467 - 2.0190 1.00 3968 207 0.2087 0.2679 REMARK 3 26 2.0190 - 1.9928 1.00 3939 196 0.2205 0.2601 REMARK 3 27 1.9928 - 1.9679 1.00 3910 276 0.2179 0.2778 REMARK 3 28 1.9679 - 1.9442 1.00 3957 202 0.2394 0.2843 REMARK 3 29 1.9442 - 1.9216 0.99 3940 176 0.2529 0.2912 REMARK 3 30 1.9216 - 1.9000 1.00 3978 219 0.2607 0.2984 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.222 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.057 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 6881 REMARK 3 ANGLE : 0.858 9375 REMARK 3 CHIRALITY : 0.056 1014 REMARK 3 PLANARITY : 0.006 1189 REMARK 3 DIHEDRAL : 15.878 4138 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6SK2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1292103847. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.984002 REMARK 200 MONOCHROMATOR : SI (111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 131286 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 48.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 14.20 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 14.60 REMARK 200 R MERGE FOR SHELL (I) : 0.94100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.6.0 REMARK 200 STARTING MODEL: 5O9T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG8K, 100MM SODIUM CITRATE PH REMARK 280 5.6, 100MM MGCL2, 100MM NACL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 39.40900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 89.22100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.40900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 89.22100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 613 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 95 REMARK 465 GLY A 96 REMARK 465 SER A 97 REMARK 465 GLU A 98 REMARK 465 PHE A 99 REMARK 465 SER A 100 REMARK 465 VAL A 101 REMARK 465 GLY A 102 REMARK 465 GLN A 103 REMARK 465 GLY A 104 REMARK 465 GLY B 95 REMARK 465 GLY B 96 REMARK 465 SER B 97 REMARK 465 GLU B 98 REMARK 465 PHE B 99 REMARK 465 SER B 100 REMARK 465 VAL B 101 REMARK 465 GLY B 102 REMARK 465 GLN B 103 REMARK 465 GLY B 104 REMARK 465 THR B 412 REMARK 465 HIS B 413 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 108 OG1 CG2 REMARK 470 MET A 109 CG SD CE REMARK 470 GLU A 110 CG CD OE1 OE2 REMARK 470 GLU A 111 CG CD OE1 OE2 REMARK 470 LYS A 114 CG CD CE NZ REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 ASN A 133 CG OD1 ND2 REMARK 470 ARG A 166 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 304 CZ NH1 NH2 REMARK 470 SER A 315 OG REMARK 470 ARG A 316 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN A 321 CG CD OE1 NE2 REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 ARG A 328 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 110 CG CD OE1 OE2 REMARK 470 LYS B 114 CG CD CE NZ REMARK 470 ASN B 133 CG OD1 ND2 REMARK 470 ARG B 166 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 170 CG CD CE NZ REMARK 470 LYS B 310 CG CD CE NZ REMARK 470 ARG B 316 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN B 321 CG CD OE1 NE2 REMARK 470 LYS B 325 CG CD CE NZ REMARK 470 ARG B 328 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 334 CG CD CE NZ REMARK 470 ARG B 355 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 414 CG CD CE NZ REMARK 470 ARG D 9 CG CD NE CZ NH1 NH2 REMARK 470 LYS F 7 CG CD CE NZ REMARK 470 ARG F 9 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 141 O HOH A 601 2.13 REMARK 500 OD1 ASN A 302 NZ LYS A 443 2.14 REMARK 500 OE1 GLU B 489 O HOH B 601 2.18 REMARK 500 OE2 GLU B 178 O HOH B 602 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O3 GOL A 502 O3 GOL A 502 2555 2.14 REMARK 500 O HOH B 740 O HOH B 896 4457 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 180 -159.02 -88.97 REMARK 500 TYR A 236 -118.27 47.99 REMARK 500 ILE A 381 -63.05 -133.62 REMARK 500 PHE A 422 -104.40 -108.10 REMARK 500 GLN A 428 -31.12 -131.03 REMARK 500 MET A 456 -134.61 41.13 REMARK 500 ASP B 191 71.83 -119.89 REMARK 500 TYR B 236 -115.27 47.67 REMARK 500 ILE B 381 -64.76 -130.71 REMARK 500 PHE B 422 -101.84 -110.15 REMARK 500 GLN B 428 -32.42 -133.84 REMARK 500 MET B 456 -131.10 48.07 REMARK 500 SER D 4 119.51 -168.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY F 2 LYS F 3 147.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 970 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH B 954 DISTANCE = 6.42 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue COA A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MYA B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE D 101 and GLY D REMARK 800 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide MYR D 201 and LYS D REMARK 800 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE F 101 and GLY F REMARK 800 2 DBREF 6SK2 A 99 496 UNP P30419 NMT1_HUMAN 99 496 DBREF 6SK2 B 99 496 UNP P30419 NMT1_HUMAN 99 496 DBREF 6SK2 D 5 8 UNP Q96NN9 AIFM3_HUMAN 5 8 DBREF 6SK2 F 5 8 UNP Q96NN9 AIFM3_HUMAN 5 8 SEQADV 6SK2 GLY A 95 UNP P30419 EXPRESSION TAG SEQADV 6SK2 GLY A 96 UNP P30419 EXPRESSION TAG SEQADV 6SK2 SER A 97 UNP P30419 EXPRESSION TAG SEQADV 6SK2 GLU A 98 UNP P30419 EXPRESSION TAG SEQADV 6SK2 GLY B 95 UNP P30419 EXPRESSION TAG SEQADV 6SK2 GLY B 96 UNP P30419 EXPRESSION TAG SEQADV 6SK2 SER B 97 UNP P30419 EXPRESSION TAG SEQADV 6SK2 GLU B 98 UNP P30419 EXPRESSION TAG SEQADV 6SK2 ACE D 101 UNP Q96NN9 ACETYLATION SEQADV 6SK2 GLY D 2 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 LYS D 3 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 SER D 4 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 ARG D 9 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 ACE F 101 UNP Q96NN9 ACETYLATION SEQADV 6SK2 GLY F 2 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 LYS F 3 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 SER F 4 UNP Q96NN9 ENGINEERED MUTATION SEQADV 6SK2 ARG F 9 UNP Q96NN9 ENGINEERED MUTATION SEQRES 1 A 402 GLY GLY SER GLU PHE SER VAL GLY GLN GLY PRO ALA LYS SEQRES 2 A 402 THR MET GLU GLU ALA SER LYS ARG SER TYR GLN PHE TRP SEQRES 3 A 402 ASP THR GLN PRO VAL PRO LYS LEU GLY GLU VAL VAL ASN SEQRES 4 A 402 THR HIS GLY PRO VAL GLU PRO ASP LYS ASP ASN ILE ARG SEQRES 5 A 402 GLN GLU PRO TYR THR LEU PRO GLN GLY PHE THR TRP ASP SEQRES 6 A 402 ALA LEU ASP LEU GLY ASP ARG GLY VAL LEU LYS GLU LEU SEQRES 7 A 402 TYR THR LEU LEU ASN GLU ASN TYR VAL GLU ASP ASP ASP SEQRES 8 A 402 ASN MET PHE ARG PHE ASP TYR SER PRO GLU PHE LEU LEU SEQRES 9 A 402 TRP ALA LEU ARG PRO PRO GLY TRP LEU PRO GLN TRP HIS SEQRES 10 A 402 CYS GLY VAL ARG VAL VAL SER SER ARG LYS LEU VAL GLY SEQRES 11 A 402 PHE ILE SER ALA ILE PRO ALA ASN ILE HIS ILE TYR ASP SEQRES 12 A 402 THR GLU LYS LYS MET VAL GLU ILE ASN PHE LEU CYS VAL SEQRES 13 A 402 HIS LYS LYS LEU ARG SER LYS ARG VAL ALA PRO VAL LEU SEQRES 14 A 402 ILE ARG GLU ILE THR ARG ARG VAL HIS LEU GLU GLY ILE SEQRES 15 A 402 PHE GLN ALA VAL TYR THR ALA GLY VAL VAL LEU PRO LYS SEQRES 16 A 402 PRO VAL GLY THR CYS ARG TYR TRP HIS ARG SER LEU ASN SEQRES 17 A 402 PRO ARG LYS LEU ILE GLU VAL LYS PHE SER HIS LEU SER SEQRES 18 A 402 ARG ASN MET THR MET GLN ARG THR MET LYS LEU TYR ARG SEQRES 19 A 402 LEU PRO GLU THR PRO LYS THR ALA GLY LEU ARG PRO MET SEQRES 20 A 402 GLU THR LYS ASP ILE PRO VAL VAL HIS GLN LEU LEU THR SEQRES 21 A 402 ARG TYR LEU LYS GLN PHE HIS LEU THR PRO VAL MET SER SEQRES 22 A 402 GLN GLU GLU VAL GLU HIS TRP PHE TYR PRO GLN GLU ASN SEQRES 23 A 402 ILE ILE ASP THR PHE VAL VAL GLU ASN ALA ASN GLY GLU SEQRES 24 A 402 VAL THR ASP PHE LEU SER PHE TYR THR LEU PRO SER THR SEQRES 25 A 402 ILE MET ASN HIS PRO THR HIS LYS SER LEU LYS ALA ALA SEQRES 26 A 402 TYR SER PHE TYR ASN VAL HIS THR GLN THR PRO LEU LEU SEQRES 27 A 402 ASP LEU MET SER ASP ALA LEU VAL LEU ALA LYS MET LYS SEQRES 28 A 402 GLY PHE ASP VAL PHE ASN ALA LEU ASP LEU MET GLU ASN SEQRES 29 A 402 LYS THR PHE LEU GLU LYS LEU LYS PHE GLY ILE GLY ASP SEQRES 30 A 402 GLY ASN LEU GLN TYR TYR LEU TYR ASN TRP LYS CYS PRO SEQRES 31 A 402 SER MET GLY ALA GLU LYS VAL GLY LEU VAL LEU GLN SEQRES 1 B 402 GLY GLY SER GLU PHE SER VAL GLY GLN GLY PRO ALA LYS SEQRES 2 B 402 THR MET GLU GLU ALA SER LYS ARG SER TYR GLN PHE TRP SEQRES 3 B 402 ASP THR GLN PRO VAL PRO LYS LEU GLY GLU VAL VAL ASN SEQRES 4 B 402 THR HIS GLY PRO VAL GLU PRO ASP LYS ASP ASN ILE ARG SEQRES 5 B 402 GLN GLU PRO TYR THR LEU PRO GLN GLY PHE THR TRP ASP SEQRES 6 B 402 ALA LEU ASP LEU GLY ASP ARG GLY VAL LEU LYS GLU LEU SEQRES 7 B 402 TYR THR LEU LEU ASN GLU ASN TYR VAL GLU ASP ASP ASP SEQRES 8 B 402 ASN MET PHE ARG PHE ASP TYR SER PRO GLU PHE LEU LEU SEQRES 9 B 402 TRP ALA LEU ARG PRO PRO GLY TRP LEU PRO GLN TRP HIS SEQRES 10 B 402 CYS GLY VAL ARG VAL VAL SER SER ARG LYS LEU VAL GLY SEQRES 11 B 402 PHE ILE SER ALA ILE PRO ALA ASN ILE HIS ILE TYR ASP SEQRES 12 B 402 THR GLU LYS LYS MET VAL GLU ILE ASN PHE LEU CYS VAL SEQRES 13 B 402 HIS LYS LYS LEU ARG SER LYS ARG VAL ALA PRO VAL LEU SEQRES 14 B 402 ILE ARG GLU ILE THR ARG ARG VAL HIS LEU GLU GLY ILE SEQRES 15 B 402 PHE GLN ALA VAL TYR THR ALA GLY VAL VAL LEU PRO LYS SEQRES 16 B 402 PRO VAL GLY THR CYS ARG TYR TRP HIS ARG SER LEU ASN SEQRES 17 B 402 PRO ARG LYS LEU ILE GLU VAL LYS PHE SER HIS LEU SER SEQRES 18 B 402 ARG ASN MET THR MET GLN ARG THR MET LYS LEU TYR ARG SEQRES 19 B 402 LEU PRO GLU THR PRO LYS THR ALA GLY LEU ARG PRO MET SEQRES 20 B 402 GLU THR LYS ASP ILE PRO VAL VAL HIS GLN LEU LEU THR SEQRES 21 B 402 ARG TYR LEU LYS GLN PHE HIS LEU THR PRO VAL MET SER SEQRES 22 B 402 GLN GLU GLU VAL GLU HIS TRP PHE TYR PRO GLN GLU ASN SEQRES 23 B 402 ILE ILE ASP THR PHE VAL VAL GLU ASN ALA ASN GLY GLU SEQRES 24 B 402 VAL THR ASP PHE LEU SER PHE TYR THR LEU PRO SER THR SEQRES 25 B 402 ILE MET ASN HIS PRO THR HIS LYS SER LEU LYS ALA ALA SEQRES 26 B 402 TYR SER PHE TYR ASN VAL HIS THR GLN THR PRO LEU LEU SEQRES 27 B 402 ASP LEU MET SER ASP ALA LEU VAL LEU ALA LYS MET LYS SEQRES 28 B 402 GLY PHE ASP VAL PHE ASN ALA LEU ASP LEU MET GLU ASN SEQRES 29 B 402 LYS THR PHE LEU GLU LYS LEU LYS PHE GLY ILE GLY ASP SEQRES 30 B 402 GLY ASN LEU GLN TYR TYR LEU TYR ASN TRP LYS CYS PRO SEQRES 31 B 402 SER MET GLY ALA GLU LYS VAL GLY LEU VAL LEU GLN SEQRES 1 D 9 ACE GLY LYS SER PHE SER LYS PRO ARG SEQRES 1 F 9 ACE GLY LYS SER PHE SER LYS PRO ARG HET ACE D 101 3 HET ACE F 101 3 HET GOL A 501 6 HET GOL A 502 6 HET COA A 503 48 HET MYA B 501 63 HET GOL B 502 6 HET MYR D 201 15 HETNAM ACE ACETYL GROUP HETNAM GOL GLYCEROL HETNAM COA COENZYME A HETNAM MYA TETRADECANOYL-COA HETNAM MYR MYRISTIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN MYA MYRISTOYL-COA FORMUL 3 ACE 2(C2 H4 O) FORMUL 5 GOL 3(C3 H8 O3) FORMUL 7 COA C21 H36 N7 O16 P3 S FORMUL 8 MYA C35 H62 N7 O17 P3 S FORMUL 10 MYR C14 H28 O2 FORMUL 11 HOH *727(H2 O) HELIX 1 AA1 THR A 108 SER A 113 1 6 HELIX 2 AA2 PHE A 119 GLN A 123 5 5 HELIX 3 AA3 ASP A 165 TYR A 180 1 16 HELIX 4 AA4 SER A 193 ARG A 202 1 10 HELIX 5 AA5 LEU A 207 GLN A 209 5 3 HELIX 6 AA6 LYS A 252 ARG A 255 5 4 HELIX 7 AA7 ARG A 258 LEU A 273 1 16 HELIX 8 AA8 ASN A 302 VAL A 309 1 8 HELIX 9 AA9 THR A 319 ARG A 328 1 10 HELIX 10 AB1 GLU A 342 LYS A 344 5 3 HELIX 11 AB2 ASP A 345 LYS A 358 1 14 HELIX 12 AB3 SER A 367 TYR A 376 1 10 HELIX 13 AB4 PRO A 430 LYS A 445 1 16 HELIX 14 AB5 GLU A 457 PHE A 461 5 5 HELIX 15 AB6 GLY A 487 VAL A 491 5 5 HELIX 16 AB7 THR B 108 SER B 113 1 6 HELIX 17 AB8 PHE B 119 GLN B 123 5 5 HELIX 18 AB9 ASP B 165 TYR B 180 1 16 HELIX 19 AC1 SER B 193 ARG B 202 1 10 HELIX 20 AC2 LEU B 207 GLN B 209 5 3 HELIX 21 AC3 LYS B 252 ARG B 255 5 4 HELIX 22 AC4 ARG B 258 LEU B 273 1 16 HELIX 23 AC5 ASN B 302 VAL B 309 1 8 HELIX 24 AC6 THR B 319 ARG B 328 1 10 HELIX 25 AC7 GLU B 342 LYS B 344 5 3 HELIX 26 AC8 ASP B 345 LYS B 358 1 14 HELIX 27 AC9 SER B 367 TYR B 376 1 10 HELIX 28 AD1 PRO B 430 LYS B 445 1 16 HELIX 29 AD2 GLU B 457 PHE B 461 5 5 HELIX 30 AD3 GLY B 487 VAL B 491 5 5 SHEET 1 AA112 PHE A 156 ALA A 160 0 SHEET 2 AA112 HIS A 211 VAL A 216 -1 O ARG A 215 N THR A 157 SHEET 3 AA112 LEU A 222 ILE A 235 -1 O VAL A 223 N VAL A 214 SHEET 4 AA112 THR A 238 VAL A 250 -1 O THR A 238 N ILE A 235 SHEET 5 AA112 ALA A 279 ALA A 283 1 O VAL A 280 N VAL A 243 SHEET 6 AA112 GLY A 468 TYR A 479 -1 O TYR A 479 N ALA A 279 SHEET 7 AA112 GLY A 292 SER A 300 -1 N HIS A 298 O GLY A 468 SHEET 8 AA112 VAL A 449 LEU A 453 -1 O ALA A 452 N TRP A 297 SHEET 9 AA112 ALA A 418 SER A 421 1 N ALA A 419 O ASN A 451 SHEET 10 AA112 VAL A 394 THR A 402 -1 N TYR A 401 O TYR A 420 SHEET 11 AA112 ILE A 382 GLU A 388 -1 N PHE A 385 O LEU A 398 SHEET 12 AA112 LEU A 338 PRO A 340 -1 N ARG A 339 O VAL A 386 SHEET 1 AA2 4 PHE A 156 ALA A 160 0 SHEET 2 AA2 4 HIS A 211 VAL A 216 -1 O ARG A 215 N THR A 157 SHEET 3 AA2 4 LEU A 222 ILE A 235 -1 O VAL A 223 N VAL A 214 SHEET 4 AA2 4 LEU A 362 PRO A 364 -1 O THR A 363 N HIS A 234 SHEET 1 AA3 3 PHE A 188 PHE A 190 0 SHEET 2 AA3 3 SER A 405 ILE A 407 -1 O THR A 406 N ARG A 189 SHEET 3 AA3 3 SER A 415 LEU A 416 -1 O LEU A 416 N SER A 405 SHEET 1 AA4 7 PHE B 156 ALA B 160 0 SHEET 2 AA4 7 HIS B 211 VAL B 216 -1 O ARG B 215 N THR B 157 SHEET 3 AA4 7 LEU B 222 ILE B 235 -1 O VAL B 223 N VAL B 214 SHEET 4 AA4 7 THR B 238 VAL B 250 -1 O THR B 238 N ILE B 235 SHEET 5 AA4 7 ALA B 279 ALA B 283 1 O VAL B 280 N VAL B 243 SHEET 6 AA4 7 LEU B 474 TYR B 479 -1 O TYR B 479 N ALA B 279 SHEET 7 AA4 7 GLY B 292 CYS B 294 -1 N GLY B 292 O TYR B 476 SHEET 1 AA5 4 PHE B 156 ALA B 160 0 SHEET 2 AA5 4 HIS B 211 VAL B 216 -1 O ARG B 215 N THR B 157 SHEET 3 AA5 4 LEU B 222 ILE B 235 -1 O VAL B 223 N VAL B 214 SHEET 4 AA5 4 LEU B 362 VAL B 365 -1 O THR B 363 N HIS B 234 SHEET 1 AA6 3 PHE B 188 PHE B 190 0 SHEET 2 AA6 3 SER B 405 ILE B 407 -1 O THR B 406 N ARG B 189 SHEET 3 AA6 3 SER B 415 LEU B 416 -1 O LEU B 416 N SER B 405 SHEET 1 AA7 4 LEU B 338 PRO B 340 0 SHEET 2 AA7 4 ILE B 382 GLU B 388 -1 O VAL B 386 N ARG B 339 SHEET 3 AA7 4 VAL B 394 THR B 402 -1 O LEU B 398 N PHE B 385 SHEET 4 AA7 4 VAL B 425 HIS B 426 -1 O VAL B 425 N PHE B 397 SHEET 1 AA8 7 LEU B 338 PRO B 340 0 SHEET 2 AA8 7 ILE B 382 GLU B 388 -1 O VAL B 386 N ARG B 339 SHEET 3 AA8 7 VAL B 394 THR B 402 -1 O LEU B 398 N PHE B 385 SHEET 4 AA8 7 ALA B 418 SER B 421 -1 O TYR B 420 N TYR B 401 SHEET 5 AA8 7 VAL B 449 LEU B 453 1 O ASN B 451 N ALA B 419 SHEET 6 AA8 7 TYR B 296 SER B 300 -1 N TRP B 297 O ALA B 452 SHEET 7 AA8 7 GLY B 468 ILE B 469 -1 O GLY B 468 N HIS B 298 LINK N GLY D 2 C ACE D 101 1555 1555 1.31 LINK NZ LYS D 3 C1 MYR D 201 1555 1555 1.32 LINK N GLY F 2 C ACE F 101 1555 1555 1.31 CISPEP 1 PRO A 288 LYS A 289 0 -11.22 CISPEP 2 PRO B 288 LYS B 289 0 -13.86 CISPEP 3 ARG B 316 ASN B 317 0 3.52 SITE 1 AC1 9 PRO A 126 LYS A 289 PRO A 290 VAL A 291 SITE 2 AC1 9 LEU A 478 TRP A 481 LYS A 482 CYS A 483 SITE 3 AC1 9 HOH A 731 SITE 1 AC2 7 LYS A 305 THR A 412 HIS A 413 LYS A 414 SITE 2 AC2 7 SER A 415 HOH A 613 HOH A 717 SITE 1 AC3 29 ARG A 115 TYR A 117 GLN A 118 PHE A 119 SITE 2 AC3 29 TRP A 120 ASN A 179 TYR A 180 VAL A 181 SITE 3 AC3 29 LEU A 248 CYS A 249 VAL A 250 ARG A 255 SITE 4 AC3 29 SER A 256 LYS A 257 ARG A 258 VAL A 259 SITE 5 AC3 29 ALA A 260 PRO A 261 GLY A 284 VAL A 285 SITE 6 AC3 29 LEU A 287 HOH A 647 HOH A 658 HOH A 767 SITE 7 AC3 29 HOH A 819 HOH A 853 HOH A 864 LYS D 3 SITE 8 AC3 29 MYR D 201 SITE 1 AC4 33 ARG B 115 TYR B 117 GLN B 118 PHE B 119 SITE 2 AC4 33 TRP B 120 ASN B 179 TYR B 180 VAL B 181 SITE 3 AC4 33 ILE B 245 ASN B 246 PHE B 247 LEU B 248 SITE 4 AC4 33 CYS B 249 VAL B 250 ARG B 255 SER B 256 SITE 5 AC4 33 ARG B 258 VAL B 259 ALA B 260 PRO B 261 SITE 6 AC4 33 THR B 268 PHE B 277 TYR B 281 THR B 282 SITE 7 AC4 33 LEU B 287 TYR B 479 HOH B 696 HOH B 702 SITE 8 AC4 33 HOH B 752 HOH B 792 HOH B 842 HOH B 855 SITE 9 AC4 33 LYS F 3 SITE 1 AC5 9 PRO B 126 LYS B 289 VAL B 291 TYR B 477 SITE 2 AC5 9 LEU B 478 TRP B 481 LYS B 482 CYS B 483 SITE 3 AC5 9 HOH B 853 SITE 1 AC6 8 TYR A 296 TYR A 401 LEU A 403 LEU A 495 SITE 2 AC6 8 GLN A 496 HOH A 663 LYS D 3 SER D 4 SITE 1 AC7 17 TRP A 120 TYR A 180 ILE A 245 PHE A 247 SITE 2 AC7 17 LEU A 248 THR A 268 PHE A 277 TYR A 281 SITE 3 AC7 17 THR A 282 ALA A 283 GLY A 284 LEU A 474 SITE 4 AC7 17 TYR A 479 COA A 503 GLY D 2 SER D 4 SITE 5 AC7 17 HOH D 302 SITE 1 AC8 8 PHE B 190 TYR B 296 TYR B 401 LEU B 403 SITE 2 AC8 8 LEU B 495 GLN B 496 LYS F 3 SER F 4 CRYST1 78.818 178.442 58.271 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012687 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005604 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017161 0.00000